These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9241012)

  • 1. Hepatotoxicity of clozapine.
    Hummer M; Kurz M; Kurzthaler I; Oberbauer H; Miller C; Fleischhacker WW
    J Clin Psychopharmacol; 1997 Aug; 17(4):314-7. PubMed ID: 9241012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked liver enzyme elevations with clozapine.
    Markowitz JS; Grinberg R; Jackson C
    J Clin Psychopharmacol; 1997 Feb; 17(1):70-1. PubMed ID: 9004073
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic administration of fluoxetine or clozapine induces oxidative stress in rat liver: a histopathological study.
    Zlatković J; Todorović N; Tomanović N; Bošković M; Djordjević S; Lazarević-Pašti T; Bernardi RE; Djurdjević A; Filipović D
    Eur J Pharm Sci; 2014 Aug; 59():20-30. PubMed ID: 24768740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine rechallenge after marked liver enzyme elevation.
    Eggert AE; Crismon ML; Dorson PG; Taylor RL
    J Clin Psychopharmacol; 1994 Dec; 14(6):425-6. PubMed ID: 7884025
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of marked liver enzyme increase during clozapine treatment: a case report and review of the literature.
    Erdogan A; Kocabasoglu N; Yalug I; Ozbay G; Senturk H
    Int J Psychiatry Med; 2004; 34(1):83-9. PubMed ID: 15242144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of liver enzyme elevations with four different neuroleptics: a retrospective review of 7,263 treatment courses.
    Gaertner I; Altendorf K; Batra A; Gaertner HJ
    J Clin Psychopharmacol; 2001 Apr; 21(2):215-22. PubMed ID: 11270919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between antipsychotic-induced elevation of liver enzymes and weight gain: a prospective study.
    Rettenbacher MA; Baumgartner S; Eder-Ischia U; Edlinger M; Graziadei I; Hofer A; Huber R; Hummer M; Kemmler G; Weiss E; Fleischhacker WW
    J Clin Psychopharmacol; 2006 Oct; 26(5):500-3. PubMed ID: 16974192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of elevated liver transaminase levels in children with blunt abdominal trauma.
    Karaduman D; Sarioglu-Buke A; Kilic I; Gurses E
    Injury; 2003 May; 34(4):249-52. PubMed ID: 12667774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of hepatotoxicity with naltrexone treatment.
    Sax DS; Kornetsky C; Kim A
    J Clin Pharmacol; 1994 Sep; 34(9):898-901. PubMed ID: 7983232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
    Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine-associated elevation in serum triglycerides.
    Gaulin BD; Markowitz JS; Caley CF; Nesbitt LA; Dufresne RL
    Am J Psychiatry; 1999 Aug; 156(8):1270-2. PubMed ID: 10450273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of neuroleptics on liver function, the hematopoietic system, blood pressure and temperature regulation. Comparison of clozapine, perazine and haloperidol by evaluating medical records].
    Bauer D; Gaertner HJ
    Pharmacopsychiatria; 1983 Jan; 16(1):23-9. PubMed ID: 6131449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of carbon tetrachloride hepatotoxicity by hypoxia.
    Shibayama Y
    Br J Exp Pathol; 1986 Dec; 67(6):909-14. PubMed ID: 3801302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
    Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
    Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of glutamic pyruvic transaminase and gamma-glutamyl transpeptidase in obesity.
    Nakamura S; Takezawa Y; Nakajima Y; Maeda T
    Tohoku J Exp Med; 1980 Dec; 132(4):473-8. PubMed ID: 6114578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pattern of gamma-glutamyl transpeptidase, alkaline phosphatase, serum glutamyl oxalate transaminase and serum glutamyl pyruvate transaminase in patients with disseminated non-seminomatous testicular tumors.
    van 't Sant P; Sleijfer DT; Schraffordt Koops H; Suurmeijer AJ; Willemse PH; De Bruijn HW; Marrink J; Ockhuizen T
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):209-15. PubMed ID: 6200328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seadragon VI: a 7-day dry saturation dive at 31 ATA. VIII. Plasma enzyme profiles.
    Goldinger JM; Nakayama H; Takeuchi H; Hong SK
    Undersea Biomed Res; 1987 Sep; 14(5):455-9. PubMed ID: 3672655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of marked liver enzyme increase during olanzapine treatment: a case report and review of the literature.
    Manceaux P; Constant E; Zdanowicz N; Jacques D; Reynaert C
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S15-7. PubMed ID: 21894094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of liver function tests in screening for intra-abdominal injuries.
    Sahdev P; Garramone RR; Schwartz RJ; Steelman SR; Jacobs LM
    Ann Emerg Med; 1991 Aug; 20(8):838-41. PubMed ID: 1854064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.